370 likes | 512 Views
Breathlessness in the Emergency Department. Dr Orlaith Scullion 11/09/15. Dyspnoea in the Emergency Department. Aims To consider common presentations of dyspnoea in adults presenting to the ED To describe appropriate initial management and treatment
E N D
Breathlessness in the Emergency Department Dr Orlaith Scullion 11/09/15
Dyspnoea in the Emergency Department • Aims • To consider common presentations of dyspnoea in adults presenting to the ED • To describe appropriate initial management and treatment • To identify patients with severe or life threatening conditions • To recognise when to involve ICU
BTS Guidelines - CAP • Community aquired • No pre-disposing conditions eg. cancer, immunosuppression • Does NOT apply to those with non-pneumonic LRTI eg. acute exacerbations of COPD / chest infections without CXR changes BTS guidelines for the management of community acquired pneumonia in adults. Thorax 2001:56;iv1-iv64
BTS Guidelines - pathogens • S pneumoniae • H influenzae • Legionella spp • S aureus • M catarrhalis • Gram negitive enteric bacilli • M pneumoniae • C pneumoniae • C psittaci • All viruses • Influenza A and B • mixed
BTS Guidelines – Clinical and Radiological Features • Not able to predict aetiological agent from clinical / radiological features • Elderly patients are more likely to present with non-specific symptoms and less likely to have fever than younger patients • Radiological resolution often lags behind clinical improvement • Radiological changes caused by atypical pathogens clear more quickly than bacterial pathogens
BTS Guidelines • Investigations (Community Rx) • CXR not necessary • SaO2 • Microbiology not recommended, mycobacterium tuberculosis and Legionella if indicated • Investigations (Hospitalise Rx) • CXR / FBC / U+E / LFT / CRP / oxygenation • Blood culture and other microbiology as indicated eg. sputum, urine, serology
BTS Guidelines - severity • Confusion (abb MSE 8 or less) • Urea > 7 mmol/l • Resp rate ≥ 30/min • BP > 90 systolic and / or ≥ 60 diastolic • Pre-existing: • Age ≥ 50 • Co-existing disease
CURB-65 • Confusion (abb MSE 8 or less) • Urea > 7 mmol/l • Resp rate ≥ 30/min • BP > 90 systolic and / or ≥ 60 diastolic • Age ≥ 65
AAH Antimicrobial Guidelines • CURB-65 score • Rountine investigations for all RTI • FBC / CRP / Blood cultures (x2) / CXR / oximetry • Additional investigations when CURB-65 >3 • Urinary antigen for Streptococcus pneumoniae and Legionella sp. / atypical pneumonia and Legionella serology / ABG
CURB-65 = 0 or 1 • Not severe • Consider discharge and home treatment • 1st: amoxicillin 500mg – 1g TID oral 7/7 • Alt: clarithromycin or doxycycline
CURB-65 = 2 • Not severe • Consider hospital supervised treatment • 1st: amoxicillin 500mg – 1g TID oral 7/7 • Alt: clarithromycin or doxycycline
CURB-65 = 3 • Severe • Inpatient treatment • 1st: amoxicillin 1g TID IV plus clarithromycin 500mg BD IV 7/7 • Alt: teicoplanin plus clarithromycin IV
CURB-65 = 4 or 5 • Very severe • Assess for ICU admission • 1st: co-amoxiclav 1.2g TID IV plus clarithromycin 500mg BD IV 7/7 • Alt: discuss with microbiology / ICU
Aspiration CAP • 1st: amoxicillin 500mg – 1g TID IV plus metrondiazole 500mg TID IV • Alt: clarithromycin plus metrondiazole
Managing Exacerbations of COPD Further Reading: NICE guideline 101 COPD in primary and secondary care 2010 • Treat in hospital: • Unable to cope at home / living alone • Severe breathlessness • Deteriorating / poor general condition • Cyanosis • Worsening peripheral oedema • Impaired level of consciousness / acute confusion • Already receiving LTOT • Significant co-morbidities • Significant CXR changes • Sats < 90%, pH < 7.35 PaO2 <7
Initial Management • Nebulisers: Salbutamol and ipratropium • Oxygen to maintain sats 92% • Antibiotics if purulent sputum or pneumonic changes on CXR: clarithromycin 500mg oral / iv +/- co-amoxiclav 1.2g iv • Steriods: prednisolone 30mg daily (100mg hydrocortisone iv)
Further Management • Consider iv aminophylline • Magnesium 2g iv (not in guideline) • NIV if persistent hypercapnic ventilatory failure despite optimal medical treatment (MAU) • IPPV (ICU) • Chest physio to help clear secretions
Severe Asthma in Adults • Moderate • ↑ symptoms • PEF >50-75% best or predicted • Severe • PEF 33-50% best or predicted • RR ≥ 25 / min • HR ≥ 110 / min • Inability to complete full sentences in one breath
Severe Asthma in Adults • Life threatening • PEF < 33% best or predicted • SpO2 < 92% • PaO2 < 8 kPa • normal PaCO2 • Silent chest • Cyanosis • Poor respiratory effort • Arrhythmia • Exhaustion, altered conscious level.
Treatment of Acute Asthma • Admit if signs of life threatening asthma • Admit if persistent signs of severe asthma after initial treatment • Pts whose PEF > 75% best or predicted one hr after treatment may be d/c home from ED unless other reasons for admission
Treatment of Acute Asthma • Oxygen (sats 94 – 98%) • B2 agonists: • Nebulised salbutamol 5mg (oxygen driven) stat • ? Need for continuous nebs • IV if not able to tolerate nebuliser • Ipratropium 500mcg neb 4-6 hrly • Steroids: 40 – 50 mg prednisolone • Magnesium 2g iv over 20 mins • Routine antibiotics not indicated
Referral to ICU • Requiring ventilatory support • Acute severe or life threatening asthma failing to respond to therapy • Deteriorating PEF • Persisting / worsening hypoxia • Hypercapnea • Resp acidosis • Exhaustion / poor resp effort • ↓ GCS or confusion • Resp arrest
Summary • BTS guidelines • Good initial assessment with obs • Treat appropriately • Get senior help early • Consider ICU
Pneumothorax • the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung. Symtoms • Pleuritic Chest Pain • SOB • Decreased exercise tolerance • Cough • Palpitations
Signs • Decreased expansion on affected side • Hyper-resonant percussion note • Tachycardia Tension Pneumothorax • Cyanosis • Displaced Trachea • Distended neck veins
Management pg 97 Handbook • Page 97 of handbook
Chest Drain Insertion • Not required for most patients • Should only be performed under guidance from experienced ED staff • Use the triangle of safety
Acute Cardiogenic Pulmonary Oedema • Cardiogenic (or hydrostatic) pulmonary oedema caused by an elevated pulmonary capillary pressure from left-sided heart failure • Most commonly due to an acute ischaemic event • Other causes include acute AR, MR, Tamponade, RAS, AKI • Iatrogenic
Signs • Acutely dyspnoeic • Sweaty • Distressed/ agitated • Cough with frothy sputum • Tachycardia • Elevated JVP • Widespread crackles throughout chest
Management • ABC apply 02 • ECG if acute STEMI refer for PCI give frusemide • Bloods including TnT ABG BNP • Drugs-Frusemide, Nitrate infusion ?Low dose diamorphine, • Consider CPAP
ICU • If patient not responding to treatment persistant severe hypoxaemia despite CPAP and appropriate medical management • Need for Ultrafiltration • Periarrest • Ensure Cardiology team also involved
Pulmonary Embolism • Pulmonary embolism is a condition in which one or more emboli, usually arising from a blood clot formed in the veins (or, rarely, in the right heart), are lodged in and obstruct the pulmonary arterial system. • This results in reduced gas exchange of the affected lung tissue, causing hypoxaemia and a reduction in cardiac output. • Large or multiple emboli may result in hypotension, syncope, shock, and sudden death.
Signs and Symptoms • Pleuritic chest pain • Shortness of breath • Palpitations • Leg swelling • Dizziness • Collapse
Management Suspect PE Examination Wells Score-high(>6) CTPA Med/low -D-dimer: if elevated CTPA Treatment dose enoxaparin unless contraindicated. PESI score to decide if suitable for outpatient management If score greater than 85 admit medically. If negative find alternative diagnosis
Lifethreatening PE • Call senior ED staff • Associated with collapse • Severe hypoxia • Lifethreatening arrhythmia • Severe Hypotension despite fluid resuscitation • Call ICU team • Alteplase 50mg thrombolysis